- Home
- SYBX vs GNS Comparison
SYBX vs GNS Comparison
Compare SYBX & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- GNS
- Stock Information
- Founded
- SYBX N/A
- GNS 2002
- Country
- SYBX United States
- GNS Singapore
- Employees
- SYBX N/A
- GNS N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- GNS Other Consumer Services
- Sector
- SYBX Health Care
- GNS Real Estate
- Exchange
- SYBX Nasdaq
- GNS Nasdaq
- Market Cap
- SYBX 17.0M
- GNS 14.5M
- IPO Year
- SYBX N/A
- GNS 2022
- Fundamental
- Price
- SYBX $1.42
- GNS $0.59
- Analyst Decision
- SYBX Hold
- GNS
- Analyst Count
- SYBX 3
- GNS 0
- Target Price
- SYBX $1.00
- GNS N/A
- AVG Volume (30 Days)
- SYBX 74.6K
- GNS 4.5M
- Earning Date
- SYBX 11-12-2024
- GNS 12-31-2024
- Dividend Yield
- SYBX N/A
- GNS N/A
- EPS Growth
- SYBX N/A
- GNS N/A
- EPS
- SYBX N/A
- GNS N/A
- Revenue
- SYBX $2,777,000.00
- GNS $23,062,754.00
- Revenue This Year
- SYBX N/A
- GNS $39.87
- Revenue Next Year
- SYBX N/A
- GNS $32.96
- P/E Ratio
- SYBX N/A
- GNS N/A
- Revenue Growth
- SYBX 292.23
- GNS 26.76
- 52 Week Low
- SYBX $1.22
- GNS $0.51
- 52 Week High
- SYBX $5.12
- GNS $9.49
- Technical
- Relative Strength Index (RSI)
- SYBX 48.54
- GNS 37.52
- Support Level
- SYBX $1.36
- GNS $0.51
- Resistance Level
- SYBX $1.88
- GNS $0.80
- Average True Range (ATR)
- SYBX 0.09
- GNS 0.10
- MACD
- SYBX -0.01
- GNS -0.03
- Stochastic Oscillator
- SYBX 11.54
- GNS 18.49
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.